PKA inhibitor
PKA (protein kinase A) inhibitors are compounds designed to block the activity of PKA, a serine/threonine protein kinase that plays a crucial role in various cellular processes by phosphorylating target proteins. PKA is activated upon binding of cAMP (cyclic adenosine monophosphate), leading to the release of its catalytic subunits and subsequent phosphorylation of downstream targets involved in metabolism, gene expression, and cell growth. Inhibiting PKA activity can disrupt these signaling pathways, potentially altering cellular responses to hormonal stimuli, neurotransmitters, and other extracellular signals. PKA inhibitors are investigated for their therapeutic potential in disorders where PKA dysregulation is implicated, such as certain cancers, metabolic diseases, and neurological disorders. Research efforts focus on developing selective PKA inhibitors that can effectively modulate PKA signaling pathways while minimizing off-target effects on normal cellular functions, aiming to improve treatment outcomes and reduce side effects associated with broad kinase inhibition.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:1 Page 1 of 1 1
